Atlantic Healthcare receives FDA agreement to initiate rolling submission of its New Drug Application for alicaforsen in the treatment of pouchitis
24th January 2017
FDA to accept sections of the regulatory application ahead of final Phase 3 data Cambridge, UK; January 24, 2017. Atlantic Healthcare plc ("Atlantic Healthcare"), an emerging trans-Atlantic pharmaceutical company with a core focus on…
Atlantic Healthcare granted U.S. patent extending IP cover of alicaforsen in the treatment of inflammatory bowel disease
7th November 2016
Patent covers use of antisense oligonucleotides to treat rectal stump inflammation and painCambridge, UK; November 7, 2016. Atlantic Healthcare plc ("Atlantic Healthcare"), an emerging trans-Atlantic pharmaceutical company with a core focus on…
Atlantic Healthcare a finalist for the pharma industry 2016 Scrip Awards
29th September 2016
Cambridge, UK; September 29, 2016. Atlantic Healthcare plc ("Atlantic Healthcare"), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces that is a finalist in the 12th Annual…
Atlantic Healthcare progresses manufacturing arrangements for globalsupply of alicaforsen
30th June 2016
Atlantic Healthcare appoints Mike Webb as Vice President of Manufacturing and partners with Avecia for commercial supply Cambridge, UK; June 30, 2016. Atlantic Healthcare plc ("Atlantic Healthcare"), an international specialty pharma company with a…
Atlantic Healthcare closes $24 million financing with founders of SalixPharmaceuticals and Clinigen Group, and LDC
21st March 2016
Investment secures funds to complete pivotal Phase 3 trial of alicaforsen in pouchitis and file for regulatory approval in North America and Europe Dr Lorin K Johnson, Scientific Founder of Salix Pharmaceutical, joins Board and Leadership team…
Atlantic Healthcare starts pivotal Phase 3 trial of Alicaforsen to treatInflammatory Bowel Disease Pouchitis
11th February 2016
Study of fast-tracked and orphan designated alicaforsen is the largest ever in pouchitis, and aims to confirm efficacy in antibiotic refractory patientsCambridge, UK, 11 February 2016. Atlantic Healthcare plc, ("Atlantic Healthcare") an…